MinichMacGregor Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

MinichMacGregor Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35	Closed	-$14.7K	–	150
2022 Q4	$14.7K	Buy	+35	New	+$14.1K	0.01%	369
2018 Q4	–	Sell	-46	Closed	-$14K	–	139
2018 Q3	$14K	Hold	46	–	–	0.01%	268
2018 Q2	$13K	Sell	46 -20	-30%	-$5.52K	0.01%	268
2018 Q1	$16K	Hold	66	–	–	0.01%	229
2017 Q4	$15K	Sell	66 -1	-1%	-$242	0.01%	237
2017 Q3	$14K	Hold	67	–	–	0.01%	235
2017 Q2	$15K	Sell	67 -6	-8%	-$1.31K	0.01%	221
2017 Q1	$14K	Sell	73 -1	-1%	-$193	0.01%	221
2016 Q4	$13K	Buy	+74	New	+$12.6K	0.01%	222

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MinichMacGregor Wealth Management's BIO Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2023, closing a stake of 35 shares — an estimated $14.7K sold.

MinichMacGregor Wealth Management first reported a position in BIO in Q4 2016 and held it in 9 quarters. The position peaked at $16K in Q1 2018. 504 funds tracked by Wall St. Rank hold BIO as of Q1 2023.

MinichMacGregor Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2023 after selling out during the quarter.
MinichMacGregor Wealth Management sold 35 Bio-Rad Laboratories Class A shares in Q1 2023, an estimated $14.7K.
MinichMacGregor Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 9 quarters.
MinichMacGregor Wealth Management's Bio-Rad Laboratories Class A position peaked at $16K in Q1 2018.
504 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.